Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Breastfeeding and the use of human milk.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline. It is intended to replace the previously issued policy statement of the American Academy of Pediatrics (AAP).

American Academy of Pediatrics (AAP) Policies are reviewed every 3 years by the authoring body, at which time a recommendation is made that the policy be retired, revised, or reaffirmed without change. Until the Board of Directors approves a revision or reaffirmation, or retires a statement, the current policy remains in effect.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Recommendations on Breastfeeding For Healthy Term Infants

  1. Pediatricians and other health care professionals should recommend human milk for all infants in whom breastfeeding is not specifically contraindicated and provide parents with complete, current information on the benefits and techniques of breastfeeding to ensure that their feeding decision is a fully informed one (Gartner, 1994; American Academy of Pediatrics [AAP] Committee on Nutrition, "Breastfeeding," 2004; Position of the American Dietetic Association [ADA], 2001).
    • When direct breastfeeding is not possible, expressed human milk should be provided (Schanler & Hurst, 1994; Lemons, Stuart, & Lemons, 1986). If a known contraindication to breastfeeding is identified, consider whether the contraindication may be temporary, and if so, advise pumping to maintain milk production. Before advising against breastfeeding or recommending premature weaning, weigh the benefits of breastfeeding against the risks of not receiving human milk.
  2. Peripartum policies and practices that optimize breastfeeding initiation and maintenance should be encouraged.
    • Education of both parents before and after delivery of the infant is an essential component of successful breastfeeding. Support and encouragement by the father can greatly assist the mother during the initiation process and during subsequent periods when problems arise. Consistent with appropriate care for the mother, minimize or modify the course of maternal medications that have the potential for altering the infant's alertness and feeding behavior (Kron, Stein, & Goddard, 1966; Ransjo-Arvidson et al., 2001). Avoid procedures that may interfere with breastfeeding or that may traumatize the infant, including unnecessary, excessive, and overvigorous suctioning of the oral cavity, esophagus, and airways to avoid oropharyngeal mucosal injury that may lead to aversive feeding behavior (Widstrom & Thingstrom-Paulson, 1993; Wolf & Glass, 1992).
  3. Healthy infants should be placed and remain in direct skin-to-skin contact with their mothers immediately after delivery until the first feeding is accomplished (Righard & Alade, 1990; Wiberg, Humble, & de Chateau, 1989; Mikiel-Kostyra, Mazur, & Boltruszko, 2002).
    • The alert, healthy newborn infant is capable of latching on to a breast without specific assistance within the first hour after birth (Righard & Alade, 1990). Dry the infant, assign Apgar scores, and perform the initial physical assessment while the infant is with the mother. The mother is an optimal heat source for the infant (Christensson et al., 1992; Van Den Bosch & Bullough, 1990). Delay weighing, measuring, bathing, needle-sticks, and eye prophylaxis until after the first feeding is completed. Infants affected by maternal medications may require assistance for effective latch-on (Righard & Alade, 1990). Except under unusual circumstances, the newborn infant should remain with the mother throughout the recovery period (Sosa et al., 1976).
  4. Supplements (water, glucose water, formula, and other fluids) should not be given to breastfeeding newborn infants unless ordered by a physician when a medical indication exists (AAP Committee on Nutrition, "Breastfeeding," 2004; AAP & American College of Obstetricians and Gynecologist [ACOG], 2002; Shrago, 1987; Goldberg & Adams, 1983, Eidelman, 2001).
  5. Pacifier use is best avoided during the initiation of breastfeeding and used only after breastfeeding is well established (Howard et al., 1999; Howard et al., 2003; Schubiger, Schwartz, & Tonz, 1997).
    • In some infants early pacifier use may interfere with establishment of good breastfeeding practices, whereas in others it may indicate the presence of a breastfeeding problem that requires intervention (Kramer et al., 2001).
    • This recommendation does not contraindicate pacifier use for nonnutritive sucking and oral training of premature infants and other special care infants.
  6. During the early weeks of breastfeeding, mothers should be encouraged to have 8 to 12 feedings at the breast every 24 hours, offering the breast whenever the infant shows early signs of hunger such as increased alertness, physical activity, mouthing, or rooting (Gunther, 1955).
    • Crying is a late indicator of hunger. Appropriate initiation of breastfeeding is facilitated by continuous rooming-in throughout the day and night (Procianoy et al., 1983). The mother should offer both breasts at each feeding for as long a period as the infant remains at the breast (Anderson, 1989). At each feed the first breast offered should be alternated so that both breasts receive equal stimulation and draining. In the early weeks after birth, nondemanding infants should be aroused to feed if 4 hours have elapsed since the beginning of the last feeding.
    • After breastfeeding is well established, the frequency of feeding may decline to approximately 8 times per 24 hours, but the infant may increase the frequency again with growth spurts or when an increase in milk volume is desired.
  7. Formal evaluation of breastfeeding, including observation of position, latch, and milk transfer, should be undertaken by trained caregivers at least twice daily and fully documented in the record during each day in the hospital after birth (Riordan et al., 2001; Hall et al., 2002).
    • Encouraging the mother to record the time and duration of each breastfeeding, as well as urine and stool output during the early days of breastfeeding in the hospital and the first weeks at home, helps to facilitate the evaluation process. Problems identified in the hospital should be addressed at that time, and a documented plan for management should be clearly communicated to both parents and to the medical home.
  8. All breastfeeding newborn infants should be seen by a pediatrician or other knowledgeable and experienced health care professional at 3 to 5 days of age as recommended by the American Association of Pediatrics (AAP) ("Management of hyperbilirubinemia," 2004; AAP Committee on Practice and Ambulatory Medicine, 2000;"Hospital stay for healthy term newborns, 1995).
    • This visit should include infant weight; physical examination, especially for jaundice and hydration; maternal history of breast problems (painful feedings, engorgement); infant elimination patterns (expect 3-5 urines and 3-4 stools per day by 3-5 days of age; 4-6 urines and 3-6 stools per day by 5-7 days of age); and a formal, observed evaluation of breastfeeding, including position, latch, and milk transfer. Weight loss in the infant of greater than 7% from birth weight indicates possible breastfeeding problems and requires more intensive evaluation of breastfeeding and possible intervention to correct problems and improve milk production and transfer.
  9. Breastfeeding infants should have a second ambulatory visit at 2 to 3 weeks of age so that the health care professional can monitor weight gain and provide additional support and encouragement to the mother during this critical period.
  10. Pediatricians and parents should be aware that exclusive breastfeeding is sufficient to support optimal growth and development for approximately the first 6 months of life* and provides continuing protection against diarrhea and respiratory tract infection (Popkin et al., 1990; Bachrach, Schwartz, & Bachrach, 2003; American Academy of Family Physicians [AAFP], 2001; Ahn & MacClean, 1980; Brown, Dewey, & Allen, 1998; Heinig et al., 1993; Kramer & Kakuma, 2002; Chantry, Howard, & Auinger, 2002; Dewey et al., 2001; Butte, Lopez-Alarcon, & Garza, 2002). Breastfeeding should be continued for at least the first year of life and beyond for as long as mutually desired by mother and child (Sugarman & Kendall-Tackett, 1995).

    *There is a difference of opinion among AAP experts on this matter. The Section on Breastfeeding acknowledges that the Committee on Nutrition supports introduction of complementary foods between 4 and 6 months of age when safe and nutritious complementary foods are available.

    • Complementary foods rich in iron should be introduced gradually beginning around 6 months of age (Dallman, 1990; Domellof et al., 2002). Preterm and low birth weight infants and infants with hematologic disorders or infants who had inadequate iron stores at birth generally require iron supplementation before 6 months of age (AAP Committee on Nutrition, "Breastfeeding, " 2004; AAP Committee on Fetus and Newborn & ACOG, 2002; AAP Committee on Nutrition, "Nutritional needs," 2004; Pisacane, De Vizia, & Valiente, 1995; Griffin & Abrams, 2001; Dewey et al., 1998). Iron may be administered while continuing exclusive breastfeeding.
    • Unique needs or feeding behaviors of individual infants may indicate a need for introduction of complementary foods as early as 4 months of age, whereas other infants may not be ready to accept other foods until approximately 8 months of age (Naylor & Morrow, 2001).
    • Introduction of complementary feedings before 6 months of age generally does not increase total caloric intake or rate of growth and only substitutes foods that lack the protective components of human milk (Cohen et al., 1995).
    • During the first 6 months of age, even in hot climates, water and juice are unnecessary for breastfed infants and may introduce contaminants or allergens (Ashraf et al., 1993).
    • Increased duration of breastfeeding confers significant health and developmental benefits for the child and the mother, especially in delaying return of fertility (thereby promoting optimal intervals between births) (Huffman et al., 1987).
    • There is no upper limit to the duration of breastfeeding and no evidence of psychologic or developmental harm from breastfeeding into the third year of life or longer (Dettwyler, 1995).
    • Infants weaned before 12 months of age should not receive cow's milk but should receive iron-fortified infant formula ("Iron fortification of infant formulas," 1999).
  11. All breastfed infants should receive 1.0 mg of vitamin K1 oxide intramuscularly after the first feeding is completed and within the first 6 hours of life ("Controversies concerning vitamin K," 2003).
    • Oral vitamin K is not recommended. It may not provide the adequate stores of vitamin K necessary to prevent hemorrhage later in infancy in breastfed infants unless repeated doses are administered during the first 4 months of life (Hansen & Ebbesen, 1996).
  12. All breastfed infants should receive 200 IU of oral vitamin D drops daily beginning during the first 2 months of life and continuing until the daily consumption of vitamin D-fortified formula or milk is 500 mL (Gartner & Greer, 2003).
    • Although human milk contains small amounts of vitamin D, it is not enough to prevent rickets. Exposure of the skin to ultraviolet B wavelengths from sunlight is the usual mechanism for production of vitamin D. However, significant risk of sunburn (short-term) and skin cancer (long-term) attributable to sunlight exposure, especially in younger children, makes it prudent to counsel against exposure to sunlight. Furthermore, sunscreen decreases vitamin D production in skin.
  13. Supplementary fluoride should not be provided during the first 6 months of life ("Recommendations for using fluoride," 2001).
    • From 6 months to 3 years of age, the decision whether to provide fluoride supplementation should be made on the basis of the fluoride concentration in the water supply (fluoride supplementation generally is not needed unless the concentration in the drinking water is <0.3 ppm) and in other food, fluid sources, and toothpaste.
  14. Mother and infant should sleep in proximity to each other to facilitate breastfeeding (Blair et al., 1999).
  15. Should hospitalization of the breastfeeding mother or infant be necessary, every effort should be made to maintain breastfeeding, preferably directly, or pumping the breasts and feeding expressed milk if necessary.

Additional Recommendations For High-Risk Infants

  • Hospitals and physicians should recommend human milk for premature and other high-risk infants either by direct breastfeeding and/or using the mother's own expressed milk (Schanler, 2001). Maternal support and education on breastfeeding and milk expression should be provided from the earliest possible time. Mother-infant skin-to-skin contact and direct breastfeeding should be encouraged as early as feasible (Charpak et al., 1997; Hurst et al., 1997). Fortification of expressed human milk is indicated for many very low birth weight infants (Schanler, 2001). Banked human milk may be a suitable feeding alternative for infants whose mothers are unable or unwilling to provide their own milk. Human milk banks in North America adhere to national guidelines for quality control of screening and testing of donors and pasteurize all milk before distribution (Hughes, 1990; Human Milk Banking Association of North America, 2003; Arnold, 1990). Fresh human milk from unscreened donors is not recommended because of the risk of transmission of infectious agents
  • Precautions should be followed for infants with glucose-6-phosphate dehydrogenase (G6PD) deficiency. G6PD deficiency has been associated with an increased risk of hemolysis, hyperbilirubinemia, and kernicterus (Kaplan & Hammerman, 1998). Mothers who breastfeed infants with known or suspected G6PD deficiency should not ingest fava beans or medications such as nitrofurantoin, primaquine phosphate, or phenazopyridine hydrochloride, which are known to induce hemolysis in deficient individuals (Kaplan et al., 1998; Gerk et al., 2001).

Conclusions

Although economic, cultural, and political pressures often confound decisions about infant feeding, the AAP firmly adheres to the position that breastfeeding ensures the best possible health as well as the best developmental and psychosocial outcomes for the infant. Enthusiastic support and involvement of pediatricians in the promotion and practice of breastfeeding is essential to the achievement of optimal infant and child health, growth, and development.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

REFERENCES SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of evidence supporting the recommendations is not specifically stated.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1997 Dec (revised 2005 Feb)

GUIDELINE DEVELOPER(S)

American Academy of Pediatrics - Medical Specialty Society

SOURCE(S) OF FUNDING

American Academy of Pediatrics

GUIDELINE COMMITTEE

Section on Breastfeeding

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Section on Breastfeeding, 2003-2004: *Lawrence M. Gartner, MD, Chairperson; Jane Morton, MD; Ruth A. Lawrence, MD; Audrey J. Naylor, MD, DrPH; Donna O'Hare, MD; Richard J. Schanler, MD; *Arthur I. Eidelman, MD, Policy Committee Chairperson

Liaisons: Nancy F. Krebs, MD, Committee on Nutrition; Alice Lenihan, MPH, RD, LPN, National WIC Association; John Queenan, MD, American College of Obstetricians and Gynecologists

Staff: Betty Crase, IBCLC, RLC

*Lead authors

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline. It is intended to replace the previously issued policy statement of the American Academy of Pediatrics (AAP).

American Academy of Pediatrics (AAP) Policies are reviewed every 3 years by the authoring body, at which time a recommendation is made that the policy be retired, revised, or reaffirmed without change. Until the Board of Directors approves a revision or reaffirmation, or retires a statement, the current policy remains in effect.

GUIDELINE AVAILABILITY

Electronic copies: Available from the American Academy of Pediatrics (AAP) Policy Web site.

Print copies: Available from the American Academy of Pediatrics, 141 NW Point Blvd, PO Box 927, Elk Grove Village, IL 60009-0927; Web site, http://www.aap.org/

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on April 27, 1999. The information was verified by the guideline developer on July 13, 1999. This NGC summary was updated by ECRI on February 23, 2005. The information was verified by the guideline developer on May 2, 2005.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Please contact the Permissions Editor, American Academy of Pediatrics (AAP), 141 Northwest Point Blvd, Elk Grove Village, IL 60007.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo